Bacterial News and Research

RSS

Scientists suggest a new approach to mitigating the collateral damage from antibiotics

Antibiotics help us to treat bacterial infections and save millions of lives each year. But they can also harm the helpful microbes residing in our gut, weakening one of our body's first lines of defense against pathogens and compromising the multiple beneficial effects our microbiota has for our health.

13 Oct 2021

Scientists move a step closer to harnessing viruses to fight antibiotic resistance

As antibiotics increasingly develop resistance to bacteria that cause infection, scientists have moved a step closer to harnessing viruses as an alternative form of therapy.

12 Oct 2021

Long stays in space appear to cause brain damage

Spending a long time in space appears to cause brain damage. This is shown by a study of five Russian cosmonauts who had stayed on the International Space Station.

12 Oct 2021

Nucleoside modifications suppress the potential of RNA to activate dendritic cells

A new paper shows that human TLR3, TLR7, and TLR8 receptors are activated with naturally occurring RNA, but this is eliminated once modified nucleosides such as m5C, m6A, m5U s2U, or pseudouridine are incorporated.

12 Oct 2021

Development of disinfection process based on ozone for highly efficient inactivation of SARS-CoV-2

This study aimed to evaluate the ozone capacity generated within a newly developed disinfection chamber to eradicate SARS-CoV-2 from porous materials and non-porous materials like glass.

12 Oct 2021

A new bacterial two-hybrid assay to study SARS-CoV-2 interactome

Recently, scientists have developed a bacterial two-hybrid (B2H) system to study the PPIs of SARS-CoV-2 in a heterologous non-eukaryotic system. This study is available on the bioRxiv* preprint server. Put simply, the B2H system could be used to analyze the SARS-CoV-2 proteome.

11 Oct 2021

Small set of beneficial bacterial strains linked to effectiveness of fecal microbiota transplants

The effectiveness of fecal microbiota transplantation (FMT) in treating ulcerative colitis depends on a small set of beneficial bacterial strains, suggests a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

11 Oct 2021

New molecular understanding of variations in salmonella virulence

Researchers from the University of Seville, in collaboration with the universities of Zaragoza and Kansas (USA), have managed to describe hitherto unknown processes that allow us to understand the virulence of a Salmonella infection.

11 Oct 2021

Prior immunity to influenza, not SARS-CoV-2, prevents severe disease and mortality

Researchers from the Israel Institute of Biological Research delineated the interplay between IAV and SARS CoV-2 infections.

11 Oct 2021

Kidney transplant patients are more susceptible to harmless bacterium, finds study

It's a pervasive bacterium found in soil and water that rarely causes disease, but a new national review of nocardia infection in people who have had a kidney transplant shows that when it occurs it most commonly causes pneumonia and brain abscess, and reminds their physicians to stay on the lookout for it, investigators say

11 Oct 2021

New metagenome assembler can generate accurate DNA sequences

Metagenomics often involves sequencing DNA samples that can only be described as "tricky." Such DNA shows high heterogeneity, which can cause interspecies misassemblies.

11 Oct 2021

Phase I clinical trial of two Cuban recombinant protein COVID-19 vaccines

The results of Phase I clinical trials for two new COVID-19 vaccine candidates based on recombinant RDB proteins are reported.

10 Oct 2021

Adapting biological research and development to COVID-19

In this interview, News-Medical talks to Dr Yuning Chen, about the work he does with Sino Biological and how they have adapted their research & development to the COVID-19 pandemic.

From Sino Biological Inc. 8 Oct 2021

Common gut bacteria can fuel prostate cancer growth and treatment resistance

Common gut bacteria can fuel the growth of prostate cancers and allow them to evade the effects of treatment, a new study finds.

7 Oct 2021

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

A team of researchers has explored the possibility of coating surfaces with TiO2 as a tool to inactivate SARS-CoV-2.

7 Oct 2021

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Researchers at the Centre for Genomic Regulation and Pulmobiotics S.L have created the first 'living medicine' to treat antibiotic-resistant bacteria growing on the surfaces of medical implants. The researchers created the treatment by removing a common bacteria's ability to cause disease and repurposing it to attack harmful microbes instead.

6 Oct 2021

Bacterial News and Research

Scientists suggest a new approach to mitigating the collateral damage from antibiotics

Scientists move a step closer to harnessing viruses to fight antibiotic resistance

Long stays in space appear to cause brain damage

Nucleoside modifications suppress the potential of RNA to activate dendritic cells

Development of disinfection process based on ozone for highly efficient inactivation of SARS-CoV-2

A new bacterial two-hybrid assay to study SARS-CoV-2 interactome

Small set of beneficial bacterial strains linked to effectiveness of fecal microbiota transplants

New molecular understanding of variations in salmonella virulence

Prior immunity to influenza, not SARS-CoV-2, prevents severe disease and mortality

Kidney transplant patients are more susceptible to harmless bacterium, finds study

New metagenome assembler can generate accurate DNA sequences

Phase I clinical trial of two Cuban recombinant protein COVID-19 vaccines

Adapting biological research and development to COVID-19

Common gut bacteria can fuel prostate cancer growth and treatment resistance

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

A possible protective genetic polymorphism in COVID-19

Experimental vaccine shows significant promise in preventing rheumatoid arthritis

SARS-CoV-2 infection and severity are strongly associated with nasal microbiota

COVID-19 may trigger hyperglycemia by disrupting key metabolic signals to cause severe disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News